Home » Topics » Regulatory

Regulatory
RSS

New fenofibrate products launched in Japan for hyperlipidemia

Dec. 21, 2011

Abilify approved in Canada for use in new patient population

Dec. 21, 2011

FDA approves new oxybutynin gel product

Dec. 12, 2011

Onglyza obtains E.U. approval for saxagliptin combination therapy

Nov. 29, 2011

Japanese authorities expand approval of Pfizer's Diflucan

Nov. 28, 2011

FDA approves Transcept's insomnia drug Intermezzo

Nov. 24, 2011

Regeneron obtains FDA approval for Eylea

Nov. 21, 2011

FDA approves Jakafi for patients with myelofibrosis

Nov. 18, 2011

European Commission approves Pfizer's Vyndaqel for TTR-FAP

Nov. 18, 2011

Kyowa Hakko Kirin launches new formulation of second-generation antihistamine in Japan

Nov. 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...